Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Clinical management of Wilson disease.

Hedera P.

Ann Transl Med. 2019 Apr;7(Suppl 2):S66. doi: 10.21037/atm.2019.03.18. Review.

2.

Deep Brain Stimulation for Treatment of Tremor.

Lake W, Hedera P, Konrad P.

Neurosurg Clin N Am. 2019 Apr;30(2):147-159. doi: 10.1016/j.nec.2019.01.002. Review.

PMID:
30898267
3.

Wilson's disease: A master of disguise.

Hedera P.

Parkinsonism Relat Disord. 2019 Feb;59:140-145. doi: 10.1016/j.parkreldis.2019.02.016. Epub 2019 Feb 14.

PMID:
30797706
4.

"Ears of the Lynx" MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia.

Pascual B, de Bot ST, Daniels MR, França MC Jr, Toro C, Riverol M, Hedera P, Bassi MT, Bresolin N, van de Warrenburg BP, Kremer B, Nicolai J, Charles P, Xu J, Singh S, Patronas NJ, Fung SH, Gregory MD, Masdeu JC.

AJNR Am J Neuroradiol. 2019 Jan;40(1):199-203. doi: 10.3174/ajnr.A5935. Epub 2019 Jan 3.

PMID:
30606727
5.

White matter differences between essential tremor and Parkinson disease.

Juttukonda MR, Franco G, Englot DJ, Lin YC, Petersen KJ, Trujillo P, Hedera P, Landman BA, Kang H, Donahue MJ, Konrad PE, Dawant BM, Claassen DO.

Neurology. 2019 Jan 1;92(1):e30-e39. doi: 10.1212/WNL.0000000000006694. Epub 2018 Nov 30.

PMID:
30504432
6.

Confined Thalamic Deep Brain Stimulation in Refractory Essential Tremor.

Isaacs DA, Butler J, Sukul V, Rodriguez W, Pallavaram S, Tolleson C, Fang JY, Phibbs FT, Yu H, Konrad PE, Hedera P.

Stereotact Funct Neurosurg. 2018;96(5):296-304. doi: 10.1159/000493546. Epub 2018 Nov 19.

PMID:
30453287
7.

Hereditary Spastic Paraplegia Overview.

Hedera P.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2000 Aug 15 [updated 2018 Sep 27].

8.

Novel Type of Complicated Autosomal Dominant Hereditary Spastic Paraplegia Associated with Congenital Distal Arthrogryposis Type I.

Hedera P, Moretti P, Howard J, Zhao J.

Brain Sci. 2018 Jul 19;8(7). pii: E136. doi: 10.3390/brainsci8070136.

9.

Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease.

Hacker ML, DeLong MR, Turchan M, Heusinkveld LE, Ostrem JL, Molinari AL, Currie AD, Konrad PE, Davis TL, Phibbs FT, Hedera P, Cannard KR, Drye LT, Sternberg AL, Shade DM, Tonascia J, Charles D.

Neurology. 2018 Jul 31;91(5):e463-e471. doi: 10.1212/WNL.0000000000005903. Epub 2018 Jun 29.

10.

WTX101 - an investigational drug for the treatment of Wilson disease.

Weiss KH, Członkowska A, Hedera P, Ferenci P.

Expert Opin Investig Drugs. 2018 Jun;27(6):561-567. doi: 10.1080/13543784.2018.1482274. Epub 2018 Jun 8. Review.

PMID:
29806946
11.

Whole-exome sequencing for variant discovery in blepharospasm.

Tian J, Vemula SR, Xiao J, Valente EM, Defazio G, Petrucci S, Gigante AF, Rudzińska-Bar M, Wszolek ZK, Kennelly KD, Uitti RJ, van Gerpen JA, Hedera P, Trimble EJ, LeDoux MS.

Mol Genet Genomic Med. 2018 May 16. doi: 10.1002/mgg3.411. [Epub ahead of print]

12.

Hereditary Myelopathies.

Hedera P.

Continuum (Minneap Minn). 2018 Apr;24(2, Spinal Cord Disorders):523-550. doi: 10.1212/CON.0000000000000580. Review.

PMID:
29613898
13.

Can lifestyle modification slow progression of Parkinson disease?

Hedera P, Davis TL.

Neurology. 2017 Oct 24;89(17):1760-1761. doi: 10.1212/WNL.0000000000004580. Epub 2017 Sep 29. No abstract available.

PMID:
28972193
14.

Phenotypic Discordance in Siblings with Identical Compound Heterozygous PARK2 Mutations.

Isaacs D, Claassen D, Bowman AB, Hedera P.

Brain Sci. 2017 Jun 24;7(7). pii: E71. doi: 10.3390/brainsci7070071.

15.

Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.

Gracies JM, O'Dell M, Vecchio M, Hedera P, Kocer S, Rudzinska-Bar M, Rubin B, Timerbaeva SL, Lusakowska A, Boyer FC, Grandoulier AS, Vilain C, Picaut P; International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.

Muscle Nerve. 2018 Feb;57(2):245-254. doi: 10.1002/mus.25721. Epub 2017 Aug 13.

16.

Case report of novel CACNA1A gene mutation causing episodic ataxia type 2.

Isaacs DA, Bradshaw MJ, Brown K, Hedera P.

SAGE Open Med Case Rep. 2017 May 8;5:2050313X17706044. doi: 10.1177/2050313X17706044. eCollection 2017.

17.

Emerging strategies in the management of essential tremor.

Hedera P.

Ther Adv Neurol Disord. 2017 Feb;10(2):137-148. doi: 10.1177/1756285616679123. Epub 2016 Nov 30. Review.

18.

Update on the clinical management of Wilson's disease.

Hedera P.

Appl Clin Genet. 2017 Jan 13;10:9-19. doi: 10.2147/TACG.S79121. eCollection 2017. Review.

19.

Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere.

Claassen DO, McDonell KE, Donahue M, Rawal S, Wylie SA, Neimat JS, Kang H, Hedera P, Zald D, Landman B, Dawant B, Rane S.

Brain Behav. 2016 Oct 6;6(12):e00573. doi: 10.1002/brb3.573. eCollection 2016 Dec.

20.

Hyperkinetic psychogenic movement disorders remain a diagnosis at first sight.

Hedera P, Gambardella A.

Neurology. 2017 Jan 10;88(2):114-115. doi: 10.1212/WNL.0000000000003494. Epub 2016 Dec 2. No abstract available.

PMID:
27913698
21.

Poster 288 Efficacy and Safety of Repeated AbobotulinumtoxinA Injections in Adults with Lower Limb Spasticity.

Gracies JM, Esquenazi A, Brashear A, Edgley SR, O'Dell M, Hedera P, Rubin BS, Picaut P.

PM R. 2016 Sep;8(9S):S254. doi: 10.1016/j.pmrj.2016.07.461. Epub 2016 Sep 24. No abstract available.

PMID:
27673046
22.

Speech-activated Myoclonus Mimicking Stuttering in a Patient with Myoclonus-Dystonia Syndrome.

Isaacs DA, Hedera P.

Tremor Other Hyperkinet Mov (N Y). 2016 Jul 1;6:405. doi: 10.7916/D8J966FP. eCollection 2016.

23.

Hereditary and metabolic myelopathies.

Hedera P.

Handb Clin Neurol. 2016;136:769-85. doi: 10.1016/B978-0-444-53486-6.00038-7. Review.

PMID:
27430441
24.

Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease.

Claassen DO, Dobolyi DG, Isaacs DA, Roman OC, Herb J, Wylie SA, Neimat JS, Donahue MJ, Hedera P, Zald DH, Landman BA, Bowman AB, Dawant BM, Rane S.

Aging Dis. 2016 May 27;7(3):220-9. doi: 10.14336/AD.2015.1110. eCollection 2016 May.

25.

Cortical Implications of Advancing Age and Disease Duration in Parkinson's Disease Patients with Postural Instability and Gait Dysfunction.

Herb JN, Rane S, Isaacs DA, Van Wouwe N, Roman OC, Landman BA, Dawant BM, Hedera P, Zald DH, Neimat JS, Wylie SA, Donahue MJ, Claassen DO.

J Parkinsons Dis. 2016 May 5;6(2):441-51. doi: 10.3233/JPD-150753.

26.

Clinical and genetic features of cervical dystonia in a large multicenter cohort.

LeDoux MS, Vemula SR, Xiao J, Thompson MM, Perlmutter JS, Wright LJ, Jinnah HA, Rosen AR, Hedera P, Comella CL, Weissbach A, Junker J, Jankovic J, Barbano RL, Reich SG, Rodriguez RL, Berman BD, Chouinard S, Severt L, Agarwal P, Stover NP.

Neurol Genet. 2016 Apr 11;2(3):e69. doi: 10.1212/NXG.0000000000000069. eCollection 2016 Jun.

27.

Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease.

Hacker ML, Currie AD, Molinari AL, Turchan M, Millan SM, Heusinkveld LE, Roach J, Konrad PE, Davis TL, Neimat JS, Phibbs FT, Hedera P, Byrne DW, Charles D.

J Parkinsons Dis. 2016;6(1):125-31. doi: 10.3233/JPD-150712.

28.

The Allure of High-Risk Rewards in Huntington's disease.

van Wouwe NC, Kanoff KE, Claassen DO, Richard Ridderinkhof K, Hedera P, Harrison MB, Wylie SA.

J Int Neuropsychol Soc. 2016 Apr;22(4):426-35. doi: 10.1017/S1355617715001241. Epub 2015 Dec 28.

29.

Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease.

Hacker ML, Tonascia J, Turchan M, Currie A, Heusinkveld L, Konrad PE, Davis TL, Neimat JS, Phibbs FT, Hedera P, Wang L, Shi Y, Shade DM, Sternberg AL, Drye LT, Charles D.

Parkinsonism Relat Disord. 2015 Oct;21(10):1177-83. doi: 10.1016/j.parkreldis.2015.08.008. Epub 2015 Aug 11.

PMID:
26306000
30.

Strumpellin and Spartin, Hereditary Spastic Paraplegia Proteins, are Binding Partners.

Zhao J, Hedera P.

J Exp Neurosci. 2015 May 7;9:15-25. doi: 10.4137/JEN.S22969. eCollection 2015.

31.

Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial.

Tramontana MG, Molinari AL, Konrad PE, Davis TL, Wylie SA, Neimat JS, May AT, Phibbs FT, Hedera P, Gill CE, Salomon RM, Wang L, Song Y, Charles D.

J Parkinsons Dis. 2015;5(1):151-63. doi: 10.3233/JPD-140448.

PMID:
25613351
32.

The optimal pallidal target in deep brain stimulation for dystonia: a study using a functional atlas based on nonlinear image registration.

Tolleson C, Pallavaram S, Li C, Fang J, Phibbs F, Konrad P, Hedera P, D'Haese PF, Dawant BM, Davis TL.

Stereotact Funct Neurosurg. 2015;93(1):17-24. doi: 10.1159/000368441. Epub 2014 Dec 9.

33.

Spastic Paraplegia 3A.

Hedera P.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2010 Sep 21 [updated 2014 Dec 11].

34.

PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper.

Aboud AA, Tidball AM, Kumar KK, Neely MD, Han B, Ess KC, Hong CC, Erikson KM, Hedera P, Bowman AB.

Neurobiol Dis. 2015 Jan;73:204-12. doi: 10.1016/j.nbd.2014.10.002. Epub 2014 Oct 12.

35.

Botulinum toxin injection techniques for the management of adult spasticity.

Walker HW, Lee MY, Bahroo LB, Hedera P, Charles D.

PM R. 2015 Apr;7(4):417-27. doi: 10.1016/j.pmrj.2014.09.021. Epub 2014 Oct 8. Review.

PMID:
25305369
36.

A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia.

Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzińska M, Momčilović D, Jinnah HA, Frei K, Pfeiffer RF, LeDoux MS.

Mol Genet Genomic Med. 2014 May;2(3):261-72. doi: 10.1002/mgg3.67. Epub 2014 Feb 11.

37.

Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease.

Charles D, Konrad PE, Neimat JS, Molinari AL, Tramontana MG, Finder SG, Gill CE, Bliton MJ, Kao C, Phibbs FT, Hedera P, Salomon RM, Cannard KR, Wang L, Song Y, Davis TL.

Parkinsonism Relat Disord. 2014 Jul;20(7):731-7. doi: 10.1016/j.parkreldis.2014.03.019. Epub 2014 Mar 28.

38.

Can fall of blood pressure prevent falls in Parkinson disease?

Hedera P, Friedman JH.

Neurology. 2014 Apr 29;82(17):1488-9. doi: 10.1212/WNL.0000000000000370. Epub 2014 Mar 28. No abstract available.

PMID:
24682972
39.

Methods for Surgical Targeting of the STN in Early-Stage Parkinson's Disease.

Camalier CR, Konrad PE, Gill CE, Kao C, Remple MR, Nasr HM, Davis TL, Hedera P, Phibbs FT, Molinari AL, Neimat JS, Charles D.

Front Neurol. 2014 Mar 19;5:25. doi: 10.3389/fneur.2014.00025. eCollection 2014.

40.

Treatment of Wilson's disease motor complications with deep brain stimulation.

Hedera P.

Ann N Y Acad Sci. 2014 May;1315:16-23. doi: 10.1111/nyas.12372. Epub 2014 Feb 18. Review.

PMID:
24547944
41.

Pharmacotherapy of essential tremor.

Hedera P, Cibulčík F, Davis TL.

J Cent Nerv Syst Dis. 2013 Dec 22;5:43-55. doi: 10.4137/JCNSD.S6561. Review.

42.

Recurrent de novo c.316G>A mutation in NIPA1 hotspot.

Hedera P.

J Neurol Sci. 2013 Dec 15;335(1-2):231-2. doi: 10.1016/j.jns.2013.09.015. Epub 2013 Sep 17.

PMID:
24075313
43.

REEPing the benefits of an animal model of hereditary spastic paraplegia.

Deutch AY, Hedera P, Colbran RJ.

J Clin Invest. 2013 Oct;123(10):4134-6. doi: 10.1172/JCI72324. Epub 2013 Sep 24.

44.

A new locus for familial temporal lobe epilepsy on chromosome 3q.

Chahine L, Abou-Khalil B, Siren A, Andermann F, Hedera P, Ge Q, Andermann E, Pandolfo M.

Epilepsy Res. 2013 Oct;106(3):338-44. doi: 10.1016/j.eplepsyres.2013.07.007. Epub 2013 Aug 14.

PMID:
24021842
45.

Treating post-traumatic tremor with deep brain stimulation: report of five cases.

Issar NM, Hedera P, Phibbs FT, Konrad PE, Neimat JS.

Parkinsonism Relat Disord. 2013 Dec;19(12):1100-5. doi: 10.1016/j.parkreldis.2013.07.022. Epub 2013 Aug 14.

PMID:
23953511
46.

Novel polymerase gamma (POLG1) gene mutation in the linker domain associated with parkinsonism.

Dolhun R, Presant EM, Hedera P.

BMC Neurol. 2013 Jul 18;13:92. doi: 10.1186/1471-2377-13-92.

47.

FUS in familial essential tremor - the search for common causes is still on.

Hedera P, Davis TL, Phibbs FT, Charles PD, LeDoux MS.

Parkinsonism Relat Disord. 2013 Sep;19(9):818-20. doi: 10.1016/j.parkreldis.2013.04.009. Epub 2013 May 6.

PMID:
23660545
48.

Neurologist consistency in interpreting information provided by an interactive visualization software for deep brain stimulation postoperative programming assistance.

Pallavaram S, Phibbs FT, Tolleson C, Davis TL, Fang J, Hedera P, Li R, Koyama T, Dawant BM, D'Haese PF.

Neuromodulation. 2014 Jan;17(1):11-5; discussion 15. doi: 10.1111/ner.12061. Epub 2013 May 3.

49.

Surgical targets for dystonic tremor: considerations between the globus pallidus and ventral intermediate thalamic nucleus.

Hedera P, Phibbs FT, Dolhun R, Charles PD, Konrad PE, Neimat JS, Davis TL.

Parkinsonism Relat Disord. 2013 Jul;19(7):684-6. doi: 10.1016/j.parkreldis.2013.03.010. Epub 2013 Apr 20.

PMID:
23611688
50.

Metabolic hyperactivity of the medial posterior parietal lobes in psychogenic tremor.

Hedera P.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-50-441-1. doi: 10.7916/D87W69X8. Epub 2012 May 11.

Supplemental Content

Loading ...
Support Center